Javascript must be enabled to continue!
Perspectives for Generative AI-Assisted Art Therapy for Melanoma Patients
View through CrossRef
Digital technologies are making their mark in medicine, and especially also in art therapy, offering innovative therapeutic interventions for patients, including those with melanoma skin cancer. However, the integration of novel technologies, such as AI-generated art, brings along ethical, psychological, and technical challenges that are viewed differently among therapists. We aim to gauge art therapists’ views on the ethical, application, and challenge facets of utilizing AI-generated art from medical images in therapy. The focus is on assessing its applicability and limitations for melanoma patients. Art therapists were surveyed via a questionnaire focusing on their experience, digital tool familiarity, and views on AI in therapy, encompassing ethics, benefits, challenges, and applicability for melanoma. Art therapists have already implemented digital technologies and acknowledged potential therapeutic benefits of creating personalized artworks with generative artificial intelligence. Attention needs to be given to technological hurdles and the necessity for supplementary interventions. Views on the method’s adaptability varied, underscoring a need for tailored, patient-focused applications. Art therapists are welcoming AI-generated art as a promising creative therapeutic tool and acknowledge potential therapeutic benefits. There are ethical, technical, and psychological challenges that must be addressed for application in therapeutic sessions. Therapists should navigate AI integration with sensitivity, adhering to ethical norms around consent and privacy. Future studies should show the therapeutic benefit in practice with emphasis on equipping therapists to manage the technical complexities effectively. Furthermore, it is important to ensure that patients can influence the AI output, allowing for creative moments in the process.
Title: Perspectives for Generative AI-Assisted Art Therapy for Melanoma Patients
Description:
Digital technologies are making their mark in medicine, and especially also in art therapy, offering innovative therapeutic interventions for patients, including those with melanoma skin cancer.
However, the integration of novel technologies, such as AI-generated art, brings along ethical, psychological, and technical challenges that are viewed differently among therapists.
We aim to gauge art therapists’ views on the ethical, application, and challenge facets of utilizing AI-generated art from medical images in therapy.
The focus is on assessing its applicability and limitations for melanoma patients.
Art therapists were surveyed via a questionnaire focusing on their experience, digital tool familiarity, and views on AI in therapy, encompassing ethics, benefits, challenges, and applicability for melanoma.
Art therapists have already implemented digital technologies and acknowledged potential therapeutic benefits of creating personalized artworks with generative artificial intelligence.
Attention needs to be given to technological hurdles and the necessity for supplementary interventions.
Views on the method’s adaptability varied, underscoring a need for tailored, patient-focused applications.
Art therapists are welcoming AI-generated art as a promising creative therapeutic tool and acknowledge potential therapeutic benefits.
There are ethical, technical, and psychological challenges that must be addressed for application in therapeutic sessions.
Therapists should navigate AI integration with sensitivity, adhering to ethical norms around consent and privacy.
Future studies should show the therapeutic benefit in practice with emphasis on equipping therapists to manage the technical complexities effectively.
Furthermore, it is important to ensure that patients can influence the AI output, allowing for creative moments in the process.
Related Results
Precursors of skin melanoma (melanoma-sensitive nevi)
Precursors of skin melanoma (melanoma-sensitive nevi)
Interest in melanoma precursors, or melanoma-sensitive skin nevi, has not lost its relevance for many years due to the steady increase of skin melanoma morbidity in recent decades ...
Abstract 1631: Cav1 is a key mediator of tumor-stromal interactions in melanoma.
Abstract 1631: Cav1 is a key mediator of tumor-stromal interactions in melanoma.
Abstract
Several lines of experimental evidence have demonstrated the importance of the tumor microenvironment in controlling melanoma tumor growth and melanoma meta...
Abstract 4342: Histological variants and sites of presentation of malignant melanoma in a resource poor setting: A histopathological review
Abstract 4342: Histological variants and sites of presentation of malignant melanoma in a resource poor setting: A histopathological review
Abstract
Background: Melanoma is a malignant tumour that arises from melanocytic cells. The incidence is increasing worldwide in white population where fair skin peo...
YY1-induced lncRNA00511 promotes melanoma progression via the miR-150- 5p/ADAM19 axis
YY1-induced lncRNA00511 promotes melanoma progression via the miR-150- 5p/ADAM19 axis
Abstract
Background
Long noncoding RNAs (lncRNAs) are key regulators of oncogenic processes, and one such lncRNA is lncRNA511 (LINC00511), which is associated with breast,...
Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis
Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis
AbstractBackgroundConsidering melanoma is the deadliest malignancy among dermatoma and presently lacks effective therapies, there is an urgent need to investigate the potential mec...
Evolved adaptation to low ultraviolet radiation may be the main cause of malignant melanoma independent of high ultraviolet radiation levels
Evolved adaptation to low ultraviolet radiation may be the main cause of malignant melanoma independent of high ultraviolet radiation levels
Abstract
Background: The low melanin production (depigmentation) evolved in response to low ultraviolet radiation may be the principal determinant of malignant melanoma of ...
Abstract 1275: Quantitative proteomic analysis of tumor growth associated proteins in cutaneous malignant melanoma
Abstract 1275: Quantitative proteomic analysis of tumor growth associated proteins in cutaneous malignant melanoma
Abstract
BACKGROUND: The identification of proteins responsible for tumor development and regulation is of great value. In this study, we aimed to identify novel fun...
The epigenetic regulator TRIM24 controls melanoma cell dedifferentiation and resistance to treatment in melanoma
The epigenetic regulator TRIM24 controls melanoma cell dedifferentiation and resistance to treatment in melanoma
AbstractCancer cell plasticity plays a key role in tumor progression and treatment resistance in melanoma. While the transcriptional programs enabling adaptative switching between ...

